ONCOLYZE
Oncolyze is developing a disruptive technology for the treatment of cancer.
ONCOLYZE
Social Links:
Industry:
Biotechnology Health Care
Address:
New York, New York, United States
Country:
United States
Website Url:
http://www.oncolyze.com
Total Employee:
1+
Status:
Active
Technology used in webpage:
Viewport Meta IPhone / Mobile Compatible Google Analytics LetsEncrypt Google Tag Manager Google Universal Analytics Font Awesome Global Site Tag Nginx Cloudflare JS
Similar Organizations
California Cardiac Solutions
California Cardiac Solutions develop novel disruptive technology to treat heart failure.
CytoSolv
CytoSolv develops technology for the treatment of diabetic ulcers and other wounds.
Mitovation
Mitovation is developing novel infrared light (IRL) technology for the treatment of ischemic brain injuries.
Current Advisors List
Official Site Inspections
http://www.oncolyze.com Semrush global rank: 5.48 M Semrush visits lastest month: 1.56 K
- Host name: vps67923.inmotionhosting.com
- IP address: 104.247.79.136
- Location: Los Angeles United States
- Latitude: 33.956
- Longitude: -118.3887
- Metro Code: 803
- Timezone: America/Los_Angeles
- Postal: 90045
More informations about "Oncolyze"
Treating cancer by exploding cancer cells | Oncolyze
We are Oncolyze, a pre-clinical stage biopharmaceutical company that is developing a class of therapeutics to treat cancer in a new and disruptive way. What may just sound like a cool …See details»
Oncolyze - Crunchbase Company Profile & Funding
Organization. Oncolyze . Connect to CRM . Save . Summary. Financials. People. Technology. Signals & News. Similar Companies. About. Oncolyze is …See details»
Oncolyze 2025 Company Profile: Valuation, Funding & Investors
Oncolyze General Information Description. Provider of biotherapeutics services intended to treat cancer. The company develops anti-cancer drugs that combine suitably well with …See details»
Oncolyze Company Profile | Management and Employees List
Oncolyze Profile and History. Oncolyze is developing a disruptive technology for the treatment of cancer. Our novel approach uses a simple mechanism of action to selectively kill cancer cells …See details»
Oncolyze - Funding, Financials, Valuation & Investors - Crunchbase
How much funding has this organization raised over time? Show . Announced Date . Transaction Name . Number of Investors . Money Raised . Lead Investors . Access exclusive financial …See details»
Oncolyze, Inc. Company Profile | New York, NY - Dun & Bradstreet
Find company research, competitor information, contact details & financial data for Oncolyze, Inc. of New York, NY. Get the latest business insights from Dun & Bradstreet.See details»
Oncolyze - The Org
Oncolyze is developing a disruptive technology for the treatment of cancer. Our novel approach uses a simple mechanism of action to selectively kill cancer cells and cancer stem cells while …See details»
Oncolyze - Contacts, Employees, Board Members, Advisors & Alumni
Organization. Oncolyze . Connect to CRM . Save . Summary. Financials. People. Technology. Signals & News. Similar Companies. Highlights. Employee Profiles 3. ... Oncolyze has 5 board …See details»
Press Release Distribution and Management - GlobeNewswire
Jan 5, 2022 Oncolyze, a Company Aiming to Treat Cancer by Exploding Cancer Cells, is Now Accepting Investments. Own a Piece in the Future of Cancer Treatment. August 23, 2022 …See details»
Oncolyze - VentureRadar
Oncolyze is developing a disruptive technology for the treatment of cancer. Our lead drug candidate, OM-301, has a simple mechanism of action to selectively kill cancer cells and …See details»
Oncolyze, Inc. - EquityNet
Oncolyze is a late-stage preclinical company with a new anti-cancer drug with a novel mechanism of action. Oncolyze’s lead drug candidate, OM-301, can potentially treat many types of …See details»
Oncolyze, a Company Aiming to Treat Cancer by Exploding
Aug 23, 2022 Oncolyze is developing a disruptive technology for the treatment of cancer. The drug's novel approach uses a simple mechanism of action to selectively kill cancer cells and …See details»
Treating cancer by exploding cancer cells | Oncolyze
In early 2022, Oncolyze announced that the U.S. Food and Drug Administration (FDA) granted the company orphan drug designation for OM-301 for the treatment of acute myeloid leukemia …See details»
Treating Multiple Myeloma by Exploding Cancerous Cells
Apr 17, 2023 Remember that Oncolyze is a pre-clinical company. The company has promising laboratory results on 8 different myeloma cell lines and on mice, but still has a long way to go …See details»
Oncolyze - Updates, News, Events, Signals & Triggers - Crunchbase
Oncolyze is developing a disruptive technology for the treatment of cancer.See details»
Oncolyze Announces FDA Orphan Drug Designation for OM-301
Jan 5, 2022 Oncolyze is a pre-clinical stage biopharmaceutical company based in NYC that is developing a class of therapeutics to treat cancer in a new and disruptive way. The company's …See details»
New Pick: A Biotech Startup on the Verge of Curing Cancer
May 11, 2023 Oncolyze, the anti-cancer biotech startup I’m introducing to you today, has some of the most promising efficacy data that I have ever seen. Let me first explain how the cancer …See details»
Oncolyze Announces FDA Orphan Drug Designation for OM-301
Apr 11, 2023 Oncolyze is developing a disruptive technology for the treatment of cancer. Our lead drug candidate, OM-301, has a simple mechanism of action to selectively kill cancer cells …See details»
Treating cancer by exploding cancer cells | Oncolyze
Oncolyze is developing what we hope to be a transformational approach to cancer treatment. It all starts with a molecule called HDM2 (human double minute-binding protein-2). This is a protein …See details»
Explainer | China is working on oncolytic virus therapies. They …
1 day ago Could a US$140 injection shrink aggressive tumours, reawaken the immune system and even extend the life of a late-stage cancer patient? That is the potential of oncolytic virus …See details»